Holen Sie sich die Stockscreener-App
388.50
0.71%
-2.77
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ELV?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$391.27
Offen:
$392.67
24-Stunden-Volumen:
3.53M
Relative Volume:
2.10
Marktkapitalisierung:
$84.37B
Einnahmen:
$200.42B
Nettoeinkommen (Verlust:
$5.24B
KGV:
16.53
EPS:
23.5042
Netto-Cashflow:
$6.45B
1W Leistung:
-2.68%
1M Leistung:
-1.41%
6M Leistung:
+12.74%
1J Leistung:
+3.35%
1-Tages-Spanne:
$387.08
$393.91
1-Wochen-Bereich:
$387.08
$405.58
52-Wochen-Spanne:
$273.71
$426.98
Elevance Health Inc Stock (ELV) Company Profile
Firmenname
Elevance Health Inc
Sektor
Branche
Telefon
(800) 331-1476
Adresse
220 VIRGINIA AVENUE, INDIANAPOLIS
Compare ELV vs UNH, CVS, CI, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELV
Elevance Health Inc
|
388.50 | 84.37B | 200.42B | 5.24B | 6.45B | 23.50 |
UNH
Unitedhealth Group Inc
|
400.96 | 364.13B | 449.71B | 12.81B | 19.67B | 13.24 |
CVS
Cvs Health Corp
|
98.32 | 125.45B | 407.94B | 2.90B | 7.39B | 2.2771 |
CI
Cigna Group
|
279.27 | 73.88B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
360.65 | 43.30B | 137.20B | 1.15B | 1.27B | 9.3439 |
Elevance Health Inc Stock (ELV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-08 | Eingeleitet | Evercore ISI | In-line |
| 2026-02-03 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2026-01-08 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-19 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-07-21 | Herabstufung | Argus | Buy → Hold |
| 2025-07-18 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-04-15 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2025-03-17 | Hochstufung | Argus | Hold → Buy |
| 2025-01-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-10-18 | Herabstufung | Argus | Buy → Hold |
| 2024-07-18 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-06-24 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-04-27 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-28 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-09-09 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-08-22 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
Alle ansehen
Elevance Health Inc Aktie (ELV) Neueste Nachrichten
Elevance Health Stockweekly review against US health insurers - AD HOC NEWS
Elevance Tops $1B in Housing Investments: What's Driving the Strategy? - Yahoo Finance Singapore
Elevance Health Inc. stock outperforms competitors despite losses on the day - MarketWatch
Elevance Health Announces $640 Million Investment in Affordable Housing Over the Past Five Years, Surpassing $1 Billion in Total Commitment Nationwide - Business Wire
Elevance Health puts $640M into affordable housing, aiding 40,000 units - Stock Titan
Elevance Health Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Chutes & Ladders—Strive Health taps new CMO, CFO; Komodo changes leadership structure - Fierce Healthcare
Insider Sell: Ronald Penczek Sells Shares of Elevance Health Inc (ELV) - GuruFocus
TWIN CITY PRIVATE WEALTH, LLC's Elevance Health Inc(ELV) Holding History - GuruFocus
Elevance Health (ELV) CAO sells 369 shares in open-market trade - Stock Titan
Elevance Health Introduces Total Movement Care and Enhances Chronic Care Support with Connected, Personalized Services - marketscreener.com
Elevance Health Makes Chronic Care Easier to Navigate With Connected, Personalized Support - Business Wire
Elevance Health Inc Stock (US0367521038): Stock in focus after a quiet Monday setup - AD HOC NEWS
MML Focused Equity Fund's Elevance Health Inc(ELV) Holding History - GuruFocus
Insider Sell: Dixon Robert L JR Sells Shares of Elevance Health Inc (ELV) - GuruFocus
Form 144: Ronald Penczek sale of 1,531 ELV shares (ELV) - Stock Titan
Elevance Health Inc. stock outperforms competitors on strong trading day - MarketWatch
Elevance Health (ELV) director reports open-market sale of common stock - Stock Titan
Elevance Health (ELV) Stock Price, News & Analysis $ELV - MarketBeat
Elevance Health, Inc. (ELV) Latest Stock News & Headlines - Yahoo Finance
[144] Elevance Health, Inc. SEC Filing - Stock Titan
Elevance Health Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Morgan Stanley (MS) issues 300% leveraged PLUS tied to Elevance Health (ELV) stock - Stock Titan
Elevance Health Inc (ELV) Shares Fall 4.7% -- What GF Score of 9 - GuruFocus
Elevance Health Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Elevance Health Inc Stock (ELV) Moved Down by 5.03% on Jun 10: Facts Behind the Movement - TradingKey
Elevance Health (ELV) Reaffirms 2026 Earnings and Expense Guidan - GuruFocus
Elevance Health (ELV) slides as investors refocus on CMS compliance overhang ahead of key late-June deadline - Quiver Quantitative
Elevance Health Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Elevance Health Reaffirms 2026 Adjusted EPS Guidance - marketscreener.com
(ELV) Elevance Health Expects 2026 Adjusted EPS At Least $26.75, vs. FactSet Est of $26.85 - marketscreener.com
Elevance Health (NYSE: ELV) reiterates 2026 EPS and benefit ratio outlook - Stock Titan
Elevance Health stock: Is ELV underperforming the health care sector? - MSN
Elevance Health Inc. stock underperforms Tuesday when compared to competitors despite daily gains - MarketWatch
Elevance files lawsuit against former executive for noncompete violation - The Indiana Lawyer
Morgan Stanley (MS) launches 1‑year 300%‑leveraged PLUS on ELV with $1,370.50 cap - Stock Titan
Elevance Health stock hits 52-week high at 422.65 USD By Investing.com - Investing.com Nigeria
Elevance Health stock hits 52-week high at 422.65 USD - Investing.com
Elevance Health, Inc.: - marketscreener.com
Are Wall Street analysts predicting Elevance stock will climb or sink? - MSN
JPMorgan Adjusts Price Target on Elevance Health to $476 From $411, Maintains Overweight Rating - marketscreener.com
ELV Stock Quote Price and Forecast - CNN
Medicare Advantage in 2026: Enrollment Update and Key Trends - KFF
Q1 Earnings Outperformers: Elevance Health (NYSE:ELV) And The Rest Of The Health Insurance Providers Stocks - Yahoo Finance
UnitedHealth Stock Jumps 20% YTD: Should Investors Jump in Too? - TradingView
Elevance Health Inc (ELV) Stock Price, Trades & News - GuruFocus
How Investors Are Reacting To Elevance Health (ELV) Expanding Digital Access For Underserved Patients - simplywall.st
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $406.38, Implies 4% Upside - TradingView
UnitedHealth Prescribes Another Dividend Increase: Just a Lighter Dose - TradingView
Elevance Health, Inc. Stock 12‑Month Price Target Raised to $405.19, Implies 4% Upside - TradingView
Elevance Health’s Digital Equity Push Reframes Virtual Care And Investor Narrative - Yahoo Finance
Finanzdaten der Elevance Health Inc-Aktie (ELV)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.04%
0.63%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):